Selected research
Industry Research
Huoliyuan Pian Industry Research Report 2026
Market perspective
The global Huoliyuan Pian market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Huoliyuan Pian is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Huoliyuan Pian is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Huoliyuan Pian is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Huoliyuan Pian include Zhengzhou Handu Pharmaceutical Group Co., Ltd., Changbaishan Pharmaceutical Co., Ltd., Xi'an Renren Pharmaceutical Co., Ltd., Tonghua Jinma Pharmaceutical Group Co., Ltd., Tonghua Heping Pharmaceutical Co., Ltd., Tianjin Hezhi Pharmaceutical Group Co., Ltd., Taihua Natural Biopharmaceutical Co., Ltd., Shijiazhuang Dongfang Pharmaceutical Co., Ltd. and Shaanxi Dongtai Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Huoliyuan Pian market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Huoliyuan Pian Market by Company
Zhengzhou Handu Pharmaceutical Group Co., Ltd.
Changbaishan Pharmaceutical Co., Ltd.
Xi'an Renren Pharmaceutical Co., Ltd.
Tonghua Jinma Pharmaceutical Group Co., Ltd.
Tonghua Heping Pharmaceutical Co., Ltd.
Tianjin Hezhi Pharmaceutical Group Co., Ltd.
Taihua Natural Biopharmaceutical Co., Ltd.
Shijiazhuang Dongfang Pharmaceutical Co., Ltd.
Shaanxi Dongtai Pharmaceutical Co., Ltd.
Jilin Fusong Pharmaceutical Co., Ltd.
Jilin Gaomiao Pharmaceutical Co., Ltd.
Huoliyuan Pian Segment by Type
0.25g
0.3g
Other
Huoliyuan Pian Segment by Application
Hospital
Clinic
Other
Huoliyuan Pian Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Huoliyuan Pian market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Huoliyuan Pian and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Huoliyuan Pian.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Huoliyuan Pian manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Huoliyuan Pian by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Huoliyuan Pian in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.25g
- 0.3g
- Other
Applications
- Hospital
- Clinic
- Other
Companies covered
- Zhengzhou Handu Pharmaceutical Group Co., Ltd.
- Changbaishan Pharmaceutical Co., Ltd.
- Xi'an Renren Pharmaceutical Co., Ltd.
- Tonghua Jinma Pharmaceutical Group Co., Ltd.
- Tonghua Heping Pharmaceutical Co., Ltd.
- Tianjin Hezhi Pharmaceutical Group Co., Ltd.
- Taihua Natural Biopharmaceutical Co., Ltd.
- Shijiazhuang Dongfang Pharmaceutical Co., Ltd.
- Shaanxi Dongtai Pharmaceutical Co., Ltd.
- Jilin Fusong Pharmaceutical Co., Ltd.
- Jilin Gaomiao Pharmaceutical Co., Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Huoliyuan Pian Market Size (2021-2032)
- 2.2.2 Global Huoliyuan Pian Sales (2021-2032)
- 2.2.3 Global Huoliyuan Pian Market Average Price (2021-2032)
- 2.3 Huoliyuan Pian by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 0.25g
- 2.3.3 0.3g
- 2.3.4 Other
- 2.4 Huoliyuan Pian by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Huoliyuan Pian Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Huoliyuan Pian Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Huoliyuan Pian Revenue of Manufacturers (2021-2026)
- 3.4 Global Huoliyuan Pian Average Price by Manufacturers (2021-2026)
- 3.5 Global Huoliyuan Pian Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Huoliyuan Pian, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Huoliyuan Pian, Product Type & Application
- 3.8 Global Manufacturers of Huoliyuan Pian, Established Date
- 3.9 Global Huoliyuan Pian Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhengzhou Handu Pharmaceutical Group Co., Ltd.
- 4.1.1 Zhengzhou Handu Pharmaceutical Group Co., Ltd. Company Information
- 4.1.2 Zhengzhou Handu Pharmaceutical Group Co., Ltd. Business Overview
- 4.1.3 Zhengzhou Handu Pharmaceutical Group Co., Ltd. Huoliyuan Pian Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhengzhou Handu Pharmaceutical Group Co., Ltd. Huoliyuan Pian Product Portfolio
- 4.1.5 Zhengzhou Handu Pharmaceutical Group Co., Ltd. Recent Developments
- 4.2 Changbaishan Pharmaceutical Co., Ltd.
- 4.2.1 Changbaishan Pharmaceutical Co., Ltd. Company Information
- 4.2.2 Changbaishan Pharmaceutical Co., Ltd. Business Overview
- 4.2.3 Changbaishan Pharmaceutical Co., Ltd. Huoliyuan Pian Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Changbaishan Pharmaceutical Co., Ltd. Huoliyuan Pian Product Portfolio
- 4.2.5 Changbaishan Pharmaceutical Co., Ltd. Recent Developments
- 4.3 Xi'an Renren Pharmaceutical Co., Ltd.
- 4.3.1 Xi'an Renren Pharmaceutical Co., Ltd. Company Information
- 4.3.2 Xi'an Renren Pharmaceutical Co., Ltd. Business Overview
- 4.3.3 Xi'an Renren Pharmaceutical Co., Ltd. Huoliyuan Pian Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Xi'an Renren Pharmaceutical Co., Ltd. Huoliyuan Pian Product Portfolio
- 4.3.5 Xi'an Renren Pharmaceutical Co., Ltd. Recent Developments
- 4.4 Tonghua Jinma Pharmaceutical Group Co., Ltd.
- 4.4.1 Tonghua Jinma Pharmaceutical Group Co., Ltd. Company Information
- 4.4.2 Tonghua Jinma Pharmaceutical Group Co., Ltd. Business Overview
- 4.4.3 Tonghua Jinma Pharmaceutical Group Co., Ltd. Huoliyuan Pian Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Tonghua Jinma Pharmaceutical Group Co., Ltd. Huoliyuan Pian Product Portfolio
- 4.4.5 Tonghua Jinma Pharmaceutical Group Co., Ltd. Recent Developments
- 4.5 Tonghua Heping Pharmaceutical Co., Ltd.
- 4.5.1 Tonghua Heping Pharmaceutical Co., Ltd. Company Information
- 4.5.2 Tonghua Heping Pharmaceutical Co., Ltd. Business Overview
- 4.5.3 Tonghua Heping Pharmaceutical Co., Ltd. Huoliyuan Pian Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Tonghua Heping Pharmaceutical Co., Ltd. Huoliyuan Pian Product Portfolio
- 4.5.5 Tonghua Heping Pharmaceutical Co., Ltd. Recent Developments
- 4.6 Tianjin Hezhi Pharmaceutical Group Co., Ltd.
- 4.6.1 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Company Information
- 4.6.2 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Business Overview
- 4.6.3 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Huoliyuan Pian Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Huoliyuan Pian Product Portfolio
- 4.6.5 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Recent Developments
- 4.7 Taihua Natural Biopharmaceutical Co., Ltd.
- 4.7.1 Taihua Natural Biopharmaceutical Co., Ltd. Company Information
- 4.7.2 Taihua Natural Biopharmaceutical Co., Ltd. Business Overview
- 4.7.3 Taihua Natural Biopharmaceutical Co., Ltd. Huoliyuan Pian Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Taihua Natural Biopharmaceutical Co., Ltd. Huoliyuan Pian Product Portfolio
- 4.7.5 Taihua Natural Biopharmaceutical Co., Ltd. Recent Developments
- 4.8 Shijiazhuang Dongfang Pharmaceutical Co., Ltd.
- 4.8.1 Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Company Information
- 4.8.2 Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Business Overview
- 4.8.3 Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Huoliyuan Pian Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Huoliyuan Pian Product Portfolio
- 4.8.5 Shijiazhuang Dongfang Pharmaceutical Co., Ltd. Recent Developments
- 4.9 Shaanxi Dongtai Pharmaceutical Co., Ltd.
- 4.9.1 Shaanxi Dongtai Pharmaceutical Co., Ltd. Company Information
- 4.9.2 Shaanxi Dongtai Pharmaceutical Co., Ltd. Business Overview
- 4.9.3 Shaanxi Dongtai Pharmaceutical Co., Ltd. Huoliyuan Pian Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Shaanxi Dongtai Pharmaceutical Co., Ltd. Huoliyuan Pian Product Portfolio
- 4.9.5 Shaanxi Dongtai Pharmaceutical Co., Ltd. Recent Developments
- 4.10 Jilin Fusong Pharmaceutical Co., Ltd.
- 4.10.1 Jilin Fusong Pharmaceutical Co., Ltd. Company Information
- 4.10.2 Jilin Fusong Pharmaceutical Co., Ltd. Business Overview
- 4.10.3 Jilin Fusong Pharmaceutical Co., Ltd. Huoliyuan Pian Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Jilin Fusong Pharmaceutical Co., Ltd. Huoliyuan Pian Product Portfolio
- 4.10.5 Jilin Fusong Pharmaceutical Co., Ltd. Recent Developments
- 4.11 Jilin Gaomiao Pharmaceutical Co., Ltd.
- 4.11.1 Jilin Gaomiao Pharmaceutical Co., Ltd. Company Information
- 4.11.2 Jilin Gaomiao Pharmaceutical Co., Ltd. Business Overview
- 4.11.3 Jilin Gaomiao Pharmaceutical Co., Ltd. Huoliyuan Pian Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Jilin Gaomiao Pharmaceutical Co., Ltd. Huoliyuan Pian Product Portfolio
- 4.11.5 Jilin Gaomiao Pharmaceutical Co., Ltd. Recent Developments
5 Global Huoliyuan Pian Market Scenario by Region
- 5.1 Global Huoliyuan Pian Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Huoliyuan Pian Sales by Region: 2021-2032
- 5.2.1 Global Huoliyuan Pian Sales by Region: 2021-2026
- 5.2.2 Global Huoliyuan Pian Sales by Region: 2027-2032
- 5.3 Global Huoliyuan Pian Revenue by Region: 2021-2032
- 5.3.1 Global Huoliyuan Pian Revenue by Region: 2021-2026
- 5.3.2 Global Huoliyuan Pian Revenue by Region: 2027-2032
- 5.4 North America Huoliyuan Pian Market Facts & Figures by Country
- 5.4.1 North America Huoliyuan Pian Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Huoliyuan Pian Sales by Country (2021-2032)
- 5.4.3 North America Huoliyuan Pian Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Huoliyuan Pian Market Facts & Figures by Country
- 5.5.1 Europe Huoliyuan Pian Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Huoliyuan Pian Sales by Country (2021-2032)
- 5.5.3 Europe Huoliyuan Pian Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Huoliyuan Pian Market Facts & Figures by Country
- 5.6.1 Asia Pacific Huoliyuan Pian Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Huoliyuan Pian Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Huoliyuan Pian Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Huoliyuan Pian Market Facts & Figures by Country
- 5.7.1 South America Huoliyuan Pian Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Huoliyuan Pian Sales by Country (2021-2032)
- 5.7.3 South America Huoliyuan Pian Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Huoliyuan Pian Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Huoliyuan Pian Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Huoliyuan Pian Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Huoliyuan Pian Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Huoliyuan Pian Sales by Type (2021-2032)
- 6.1.1 Global Huoliyuan Pian Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Huoliyuan Pian Sales Market Share by Type (2021-2032)
- 6.2 Global Huoliyuan Pian Revenue by Type (2021-2032)
- 6.2.1 Global Huoliyuan Pian Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Huoliyuan Pian Revenue Market Share by Type (2021-2032)
- 6.3 Global Huoliyuan Pian Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Huoliyuan Pian Sales by Application (2021-2032)
- 7.1.1 Global Huoliyuan Pian Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Huoliyuan Pian Sales Market Share by Application (2021-2032)
- 7.2 Global Huoliyuan Pian Revenue by Application (2021-2032)
- 7.2.1 Global Huoliyuan Pian Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Huoliyuan Pian Revenue Market Share by Application (2021-2032)
- 7.3 Global Huoliyuan Pian Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Huoliyuan Pian Value Chain Analysis
- 8.1.1 Huoliyuan Pian Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Huoliyuan Pian Production Mode & Process
- 8.2 Huoliyuan Pian Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Huoliyuan Pian Distributors
- 8.2.3 Huoliyuan Pian Customers
9 Global Huoliyuan Pian Analyzing Market Dynamics
- 9.1 Huoliyuan Pian Industry Trends
- 9.2 Huoliyuan Pian Industry Drivers
- 9.3 Huoliyuan Pian Industry Opportunities and Challenges
- 9.4 Huoliyuan Pian Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst